ARTICLE | Company News
Crucell, NatImmune deal
September 9, 2002 7:00 AM UTC
NatImmune will evaluate the production of the therapeutic protein mannan-binding lectin (MBL) on CRXL's PER.C6 cells. NatImmune has an option to a non-exclusive commercial product license to manufact...